15-74035800-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000268059.10(PML):​c.2339G>T​(p.Gly780Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.363 in 1,613,738 control chromosomes in the GnomAD database, including 107,662 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.36 ( 9892 hom., cov: 32)
Exomes 𝑓: 0.36 ( 97770 hom. )

Consequence

PML
ENST00000268059.10 missense

Scores

15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.320

Publications

36 publications found
Variant links:
Genes affected
PML (HGNC:9113): (PML nuclear body scaffold) The protein encoded by this gene is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. This phosphoprotein localizes to nuclear bodies where it functions as a transcription factor and tumor suppressor. Its expression is cell-cycle related and it regulates the p53 response to oncogenic signals. The gene is often involved in the translocation with the retinoic acid receptor alpha gene associated with acute promyelocytic leukemia (APL). Extensive alternative splicing of this gene results in several variations of the protein's central and C-terminal regions; all variants encode the same N-terminus. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=3.7407875E-4).
BP6
Variant 15-74035800-G-T is Benign according to our data. Variant chr15-74035800-G-T is described in ClinVar as Benign. ClinVar VariationId is 403330.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.414 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PMLNM_033238.3 linkc.1710+1270G>T intron_variant Intron 7 of 8 ENST00000268058.8 NP_150241.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PMLENST00000268058.8 linkc.1710+1270G>T intron_variant Intron 7 of 8 1 NM_033238.3 ENSP00000268058.3

Frequencies

GnomAD3 genomes
AF:
0.358
AC:
54347
AN:
151898
Hom.:
9887
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.318
Gnomad AMI
AF:
0.137
Gnomad AMR
AF:
0.423
Gnomad ASJ
AF:
0.227
Gnomad EAS
AF:
0.413
Gnomad SAS
AF:
0.278
Gnomad FIN
AF:
0.408
Gnomad MID
AF:
0.259
Gnomad NFE
AF:
0.371
Gnomad OTH
AF:
0.355
GnomAD2 exomes
AF:
0.363
AC:
91105
AN:
250864
AF XY:
0.356
show subpopulations
Gnomad AFR exome
AF:
0.317
Gnomad AMR exome
AF:
0.447
Gnomad ASJ exome
AF:
0.235
Gnomad EAS exome
AF:
0.402
Gnomad FIN exome
AF:
0.415
Gnomad NFE exome
AF:
0.362
Gnomad OTH exome
AF:
0.360
GnomAD4 exome
AF:
0.363
AC:
531103
AN:
1461724
Hom.:
97770
Cov.:
56
AF XY:
0.360
AC XY:
262010
AN XY:
727160
show subpopulations
African (AFR)
AF:
0.318
AC:
10648
AN:
33478
American (AMR)
AF:
0.440
AC:
19666
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.238
AC:
6230
AN:
26136
East Asian (EAS)
AF:
0.430
AC:
17085
AN:
39700
South Asian (SAS)
AF:
0.281
AC:
24270
AN:
86256
European-Finnish (FIN)
AF:
0.414
AC:
22099
AN:
53328
Middle Eastern (MID)
AF:
0.258
AC:
1487
AN:
5766
European-Non Finnish (NFE)
AF:
0.368
AC:
408807
AN:
1111942
Other (OTH)
AF:
0.345
AC:
20811
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
22005
44011
66016
88022
110027
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13016
26032
39048
52064
65080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.358
AC:
54382
AN:
152014
Hom.:
9892
Cov.:
32
AF XY:
0.358
AC XY:
26597
AN XY:
74276
show subpopulations
African (AFR)
AF:
0.318
AC:
13166
AN:
41460
American (AMR)
AF:
0.423
AC:
6464
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.227
AC:
786
AN:
3470
East Asian (EAS)
AF:
0.414
AC:
2125
AN:
5132
South Asian (SAS)
AF:
0.277
AC:
1333
AN:
4810
European-Finnish (FIN)
AF:
0.408
AC:
4315
AN:
10580
Middle Eastern (MID)
AF:
0.269
AC:
79
AN:
294
European-Non Finnish (NFE)
AF:
0.371
AC:
25236
AN:
67956
Other (OTH)
AF:
0.356
AC:
753
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1794
3587
5381
7174
8968
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
522
1044
1566
2088
2610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.360
Hom.:
21813
Bravo
AF:
0.355
TwinsUK
AF:
0.361
AC:
1340
ALSPAC
AF:
0.369
AC:
1422
ESP6500AA
AF:
0.321
AC:
1412
ESP6500EA
AF:
0.359
AC:
3088
ExAC
AF:
0.359
AC:
43607
Asia WGS
AF:
0.355
AC:
1235
AN:
3478
EpiCase
AF:
0.347
EpiControl
AF:
0.342

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

PML-related disorder Benign:1
Oct 17, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.76
T
BayesDel_noAF
Benign
-0.72
CADD
Benign
2.2
DANN
Benign
0.23
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.074
N
LIST_S2
Benign
0.44
T;T
MetaRNN
Benign
0.00037
T;T
MetaSVM
Benign
-0.91
T
PhyloP100
0.32
PROVEAN
Benign
-0.18
N;N
REVEL
Benign
0.013
Sift
Benign
0.22
T;T
Sift4G
Benign
0.28
T;T
Polyphen
0.077
B;B
Vest4
0.080
ClinPred
0.0020
T
GERP RS
-2.4
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs743581; hg19: chr15-74328141; COSMIC: COSV51443888; COSMIC: COSV51443888; API